Table 1.
Demographic and clinical data of subjects of the study
| Study sample, n=150 | n (%) or mean ± SD |
|---|---|
| Age (years), mean ± SD | 14.7±1.6 |
| Patients under the age of 15, n (%) | 68 (45.3) |
| Sex, n (%) | |
| Male n (%) | 69 (45.7) |
| Female n (%) | 81 (53.6) |
| Education, n (%) | |
| None | 21 (14) |
| Primary school | 1 (0.7) |
| Secondary school | 50 (33.3) |
| High school | 78 (52) |
| Research diagnosis, n (%) | |
| PS | 20 (13.3) |
| PRS | 59 (39.3) |
| CC | 71 (47.3) |
| DSM-5 diagnoses, n (%) | |
| Mood disorders | 67 (44.7) |
| Anxiety disorders | 107 (71.3) |
| Obsessive-compulsive disorders | 20 (13.3) |
| Attention-deficit hyperactivity disorders | 63 (42.0) |
| Post-traumatic stress disorder | 10 (6.7) |
| Other | 60 (40) |
| Medications, n (%) | |
| Antidepressants | 55 (36.7) |
| Antipsychotics | 44 (29.3) |
| Sedatives/Hypnotics | 28 (18.7) |
| Mood stabilizers | 6 (4) |
| Other | 25 (16.8) |
| Clinical Assessment, mean ± SD | |
| The total score of SOPS | 45.78±21.91 |
| The total score of PANSS | 77.32±24.32 |
| Global assessment of functioning | 45.89±19.27 |
| Beck Depression Inventory | 19.77±12.99 |
CC, clinical controls; DSM-5, the Diagnostic and Statistical Manual of Mental Disorders; GAF, global assessment of functioning; PANSS, the Positive and Negative Symptoms Scale; PRS, psychosis risk syndrome; PS, psychotic syndrome; SD, standard deviation; SOPS, the Scale of Prodromal Symptoms.